Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference - WMBB News 13 - The Panhandle's News Leader
Wednesday, May 15 2013 11:45 AM EDT2013-05-15 15:45:20 GMT
While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week. What is pneumonia? PneumoniaMore >>
While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week.More >>
Wednesday, May 8 2013 9:06 AM EDT2013-05-08 13:06:30 GMT
We all have our aches in our bellies and backs from time to time, but these pains can also be signs of gallstones. Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones areMore >>
Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones are what's going around.More >>
Medical Central is the source for local doctors to advertise their businesses, as well as provide clients and viewers with valuable information on their fields of study.More >>
Jessica Foster is originally from Atlanta, Georgia and has worked at WMBB since 2004. She is excited to bring the news to you each weekday on News13 This Morning. Jessica produces 3 medical segments weekly- What's Going Around, Modern Medicine and Mayo Clinic reports.More >>
Medical Central is the source for local doctors to advertise their businesses, as well as provide clients and viewers with valuable information on their fields of study.More >>
Jessica Foster is originally from Atlanta, Georgia and has worked at WMBB since 2004. She is excited to bring the news to you each weekday on News13 This Morning. Jessica produces 3 medical segments weekly- What's Going Around, Modern Medicine and Mayo Clinic reports.More >>
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Orexigen Therapeutics, Inc.
SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Cowen & Co. Annual Health Care Conference in Boston. The presentation is scheduled for Monday, March 4, 2013 at 3:30 p.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.
About Orexigen® Therapeutics Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.
Orexigen Contact:
Media Contact:
McDavid Stilwell
Denise Powell
VP, Corporate Communications and Business Development